Status:
UNKNOWN
Immune- and Microenvironment- Proteogenomics Profiling for Classifying Lung Cancer Patients
Lead Sponsor:
Universidade Nova de Lisboa
Collaborating Sponsors:
Fundação para a Ciência e a Tecnologia
Hospital Cuf Descobertas
Conditions:
Lung Cancer
Malignancy
Eligibility:
All Genders
18+ years
Brief Summary
The excessive accumulation of fluid between the membranes surrounding the lung, a clinical condition commonly referred to as "pleural effusion", is caused by one of three factors: increased production...
Detailed Description
The excessive accumulation of fluid between the membranes surrounding the lung, a clinical condition commonly referred to as "pleural effusion", is caused by one of three factors: increased production...
Eligibility Criteria
Inclusion
- Candidate for diagnostic thoracentesis.
- The General Data Protection Regulation (Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016) and the Law on Personal Genetic Information and Health Information (Decree-Law no. 131/2014) is fulfilled.
- Participation in the Study is completely voluntary.
- It is possible to drop out of the study at any time without affecting the quality of medical care.
- The information obtained from this study may originate scientific publications, without jeopardizing the anonymity of the Participants.
- During the course of the Study, it is possible to ask the investigators questions that you consider convenient.
- This study does not impose any cost on the participants.
Exclusion
- Participants with unstable / severe medical illness (per investigator's judgment), coagulopathies and / or bleeding disorders, immunodeficiency syndromes (primary or acquired - including HIV infection), active and untreated HCV infection, HBV and active history of intravenous drug addictions.
Key Trial Info
Start Date :
October 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04887545
Start Date
October 1 2018
End Date
December 1 2022
Last Update
May 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital CUF Descorbertas
Lisbon, Parque Das Nacoes, Portugal, 1998-018